Industry FDA Puts Clinical Hold on uniQure's Hope B Trial Industry Catalyst Announces New FDA Designation and Phase 3 MarzAA Study Design Industry Pfizer Announces First Participant Dosed Phase 3 Study of Marstacimab Industry uniQure Announces Positive Results from Phase 3 Gene Therapy Trial Industry Global Dosing Hold in Fitusiran Trials Initiated… In the Media With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies Industry First Patient Dosed in Phase 3 Gene Therapy Trial Industry CSL Behring States Stimate Will Not Be Resupplied until 2022 Industry Sanofi Publishes Updates to BIVV001 Trial Industry BioMarin’s New Clinical Study to Focus on Antibody Development to AAVs Industry Mylan Initiates Voluntary… Industry FDA Recommends Additional Data for BioMarin’s Investigational Gene Therapy… Industry Novo Nordisk Announces Near Resumption of Concizumab Trials Industry Stimate Recall Update Industry Genentech Presents New Hemlibra® Safety Data During Virtual ISTH Congress… Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
